Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo.
Zeng Z, Li S, Ye X, Wang Y, Wang Q, Chen Z, Wang Z, Zhang J, Wang Q, Chen L, Zhang S, Zou Z, Lin M, Chen X, Zhao G, McAlinden C, Lei H, Zhou X, Huang J.
Adv Sci (Weinh). 2024 Jul;11(25):e2401710. doi: 10.1002/advs.202401710. Epub 2024 Apr 6.
Global developments in social prescribing.
Morse DF, Sandhu S, Mulligan K, Tierney S, Polley M, Chiva Giurca B, Slade S, Dias S, Mahtani KR, Wells L, Wang H, Zhao B, De Figueiredo CEM, Meijs JJ, Nam HK, Lee KH, Wallace C, Elliott M, Mendive JM, Robinson D, Palo M, Herrmann W, Østergaard Nielsen R, Husk K.
BMJ Glob Health. 2022 May;7(5):e008524. doi: 10.1136/bmjgh-2022-008524.
Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors.
Pu C, Cui H, Yu H, Cheng X, Zhang M, Qin L, Ning Z, Zhang W, Chen S, Qian Y, Wang F, Wang L, Lin X, Gennert D, Pun FW, Ren F, Zhavoronkov A.
Nat Commun. 2025 May 23;16(1):4793. doi: 10.1038/s41467-025-59874-0.
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor.
Chocarro L, Bocanegra A, Blanco E, Fernández-Rubio L, Arasanz H, Echaide M, Garnica M, Ramos P, Piñeiro-Hermida S, Vera R, Escors D, Kochan G.
Cells. 2022 Jul 30;11(15):2351. doi: 10.3390/cells11152351.
The Amsterdam Modeling Suite.
Baerends EJ, Aguirre NF, Austin ND, Autschbach J, Bickelhaupt FM, Bulo R, Cappelli C, van Duin ACT, Egidi F, Fonseca Guerra C, Förster A, Franchini M, Goumans TPM, Heine T, Hellström M, Jacob CR, Jensen L, Krykunov M, van Lenthe E, Michalak A, Mitoraj MM, Neugebauer J, Nicu VP, Philipsen P, Ramanantoanina H, Rüger R, Schreckenbach G, Stener M, Swart M, Thijssen JM, Trnka T, Visscher L, Yakovlev A, van Gisbergen S.
J Chem Phys. 2025 Apr 28;162(16):162501. doi: 10.1063/5.0258496.
Immunotherapies for NSCLC: Are We Cutting the Gordian Helix?
Dempke WC, Sellmann L, Fenchel K, Edvardsen K.
Anticancer Res. 2015 Nov;35(11):5745-57.
What's on the horizon for community-based conservation? Emerging threats and opportunities.
Esmail N, McPherson JM, Abulu L, Amend T, Amit R, Bhatia S, Bikaba D, Brichieri-Colombi TA, Brown J, Buschman V, Fabinyi M, Farhadinia M, Ghayoumi R, Hay-Edie T, Horigue V, Jungblut V, Jupiter S, Keane A, Macdonald DW, Mahajan SL, McVey A, Moehrenschlager A, Nelson F, Noshirwani MM, Ntiamoa-Baidu Y, Postigo JL, Rakotondrazafy V, Rao M, Roe D, Sierra Huelsz JA, Stolton S, Tawake A, Wintle B.
Trends Ecol Evol. 2023 Jul;38(7):666-680. doi: 10.1016/j.tree.2023.02.008. Epub 2023 Mar 17.
Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome.
Bauernfeind F, Bartok E, Rieger A, Franchi L, Núñez G, Hornung V.
J Immunol. 2011 Jul 15;187(2):613-7. doi: 10.4049/jimmunol.1100613. Epub 2011 Jun 15.
Expert opinion on NSCLC small specimen biomarker testing - Part 1: Tissue collection and management.
Penault-Llorca F, Kerr KM, Garrido P, Thunnissen E, Dequeker E, Normanno N, Patton SJ, Fairley J, Kapp J, de Ridder D, Ryška A, Moch H.
Virchows Arch. 2022 Sep;481(3):335-350. doi: 10.1007/s00428-022-03343-2. Epub 2022 Jul 20.
An Energy Metabolism Nanoblocker for Cutting Tumor Cell Respiration and Inhibiting Mitochondrial Hijacking from Cytotoxic T Lymphocyte.
Leng X, Yang Y, Jiang T, Zheng J, Zhang L, Huang J, Xu H, Fang M, Li X, Wang Z, Ge M, Lin H.
Adv Healthc Mater. 2025 Jun;14(16):e2405174. doi: 10.1002/adhm.202405174. Epub 2025 Mar 16.
